Literature DB >> 24002004

MSI2 expression is decreased in grade II of gastric carcinoma.

Modjtaba Emadi-Baygi1, Parvaneh Nikpour, Faezeh Mohammad-Hashem, Mohamad Reza Maracy, Shaghayegh Haghjooy-Javanmard.   

Abstract

Gastric cancer is the second most frequent cause of cancer death worldwide. In Iran, gastric cancer is the first cause of national cancer-related mortality in men and the second one in women. In mammals, the Musashi family of RNA binding proteins comprises the Musashi1 and Musashi2 proteins, encoded by the MSI1 and MSI2 genes. Mammalian Musashi contributes to the self-renewal of various types of stem cells. Furthermore, there is mounting evidence that stem cells exist in many tissues. Due to this, Msi appears to be associated with tumorigenesis. In the present study, 30 paired gastric tissue samples were examined for MSI2 gene expression by quantitative real-time RT-PCR. Our results demonstrated that the relative expression of the gene did not significantly alter between tumoral and non-tumoral tissues and different tumor types; but there was a statistical difference between the MSI2 gene expression in different tumor grades, of note between grade I and grade II.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Gastric cancer; Gene expression; MSI2

Mesh:

Substances:

Year:  2013        PMID: 24002004     DOI: 10.1016/j.prp.2013.07.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  12 in total

1.  Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway.

Authors:  Ming-Hai Wang; Shi-Yong Qin; Shu-Guang Zhang; Guang-Xin Li; Zhen-Hai Yu; Kun Wang; Bin Wang; Mu-Jian Teng; Zhi-Hai Peng
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.

Authors:  Kun Guo; Jiujie Cui; Ming Quan; Dacheng Xie; Zhiliang Jia; Daoyan Wei; Liang Wang; Yong Gao; Qingyong Ma; Keping Xie
Journal:  Clin Cancer Res       Date:  2016-07-22       Impact factor: 12.531

Review 3.  The functional relevance of somatic synonymous mutations in melanoma and other cancers.

Authors:  Valer Gotea; Jared J Gartner; Nouar Qutob; Laura Elnitski; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2015-11       Impact factor: 4.693

4.  Gene Expression Analysis of Two Epithelial-mesenchymal Transition-related Genes: Long Noncoding RNA-ATB and SETD8 in Gastric Cancer Tissues.

Authors:  Nooshin Nourbakhsh; Modjtaba Emadi-Baygi; Rasoul Salehi; Parvaneh Nikpour
Journal:  Adv Biomed Res       Date:  2018-03-27

5.  Augmented expression levels of lncRNAs ecCEBPA and UCA1 in gastric cancer tissues and their clinical significance.

Authors:  Mojdeh Nasrollahzadeh-Khakiani; Modjtaba Emadi-Baygi; Parvaneh Nikpour
Journal:  Iran J Basic Med Sci       Date:  2017-10       Impact factor: 2.699

6.  Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer.

Authors:  Ziguo Yang; Jie Li; Yulong Shi; Leping Li; Xiaobo Guo
Journal:  Oncol Lett       Date:  2019-01-04       Impact factor: 2.967

7.  Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.

Authors:  Weiwei Sheng; Ming Dong; Chuanping Chen; Yang Li; Qingfeng Liu; Qi Dong
Journal:  Oncotarget       Date:  2016-04-15

8.  Musashi-2 is a prognostic marker for the survival of patients with cervical cancer.

Authors:  Yaqiong Liu; Yi Fan; Xiaoyu Wang; Zijian Huang; Kun Shi; Bei Zhou
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

9.  RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression.

Authors:  Jing Zhao; Yu Zhang; Xi-Sheng Liu; Fang-Ming Zhu; Feng Xie; Chen-Yi Jiang; Zi-Ye Zhang; Ying-Li Gao; Yong-Chuan Wang; Bin Li; Shu-Jie Xia; Bang-Min Han
Journal:  Cancer Sci       Date:  2020-01-04       Impact factor: 6.716

10.  Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.

Authors:  Weiwei Sheng; Xiaoyang Shi; Yiheng Lin; Jingtong Tang; Chao Jia; Rongxian Cao; Jian Sun; Guosen Wang; Lei Zhou; Ming Dong
Journal:  J Exp Clin Cancer Res       Date:  2020-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.